ARTELO BIOSCIENCES, INC. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/92718038-6753-4d06-909e-0c64ad8b967e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-11.4M | 2025-01-01 – 2025-12-31 | evidence 0001640334-26-000368 |
| FY 2024 | $-10.1M | 2024-01-01 – 2024-12-31 | evidence 0001640334-25-000335 |
| FY 2023 | $-9.9M | 2023-01-01 – 2023-12-31 | evidence 0001640334-24-000473 |
| FY 2022 | $-10.3M | 2022-01-01 – 2022-12-31 | evidence 0001640334-23-000509 |
| FY 2021 | $-9.4M | 2021-01-01 – 2021-12-31 | evidence 0001640334-23-000509 |
| FY 2020 | $-4.7M | 2019-09-01 – 2020-08-31 | evidence 0001640334-21-002983 |
| FY 2019 | $-3.2M | 2018-09-01 – 2019-08-31 | evidence 0001640334-19-002443 |
| FY 2018 | $-2.3M | 2017-09-01 – 2018-08-31 | evidence 0001640334-18-002309 |
| FY 2017 | $-232.8k | 2016-09-01 – 2017-08-31 | evidence 0001640334-17-002551 |
| FY 2016 | $-29.7k | 2015-09-01 – 2016-08-31 | evidence 0001640334-16-002136 |
| FY 2015 | $-15.2k | 2014-09-01 – 2015-08-31 | evidence 0001640334-15-000413 |
| FY 2014 | $-15.3k | 2013-09-01 – 2014-08-31 | evidence 0001640334-15-000413 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).